Monday Movers In Biotech: Cempra Inc (CEMP) And IntelliPharmaCeutics Intl Inc (USA) (IPCI)
It’s going to be a good start to the week for a few companies in the biotech space, after a raft of positive news hit the wires on Friday. Here’s...
Posts Tagged ‘Cempra Inc (CEMP)’
Nvidia (NVDA) Can’t Shake Citron, Cempra (CEMP) Slammed by FDA Rejection, Plus 3 Other Major Movers
The second-to-last trading day of 2016 is showing little volatility in the broader market, with the S&P, Dow, and Nasdaq all being close to flat (...
Why Chipotle, Baidu, Cempra, and More Are in the Spotlight
On the day before election day, all three indexes have opened up in the green after the FBI cleared Hillary Clinton on the email matter. In this article...
Biotech Movers on Thursday: Cempra Inc (CEMP) And Opexa Therapeutics Inc (OPXA)
Another big day in the biotech sector? You bet. Things are hotting up across the space as the final quarter approaches mid-point, and we’ve had a number...
Why Brocade, Cempra, Apple, and Two Other Stocks Are in Spotlight Today
WTI futures are down 3% today after the EIA reported that oil inventories rose by 14.4 million barrels last week. That number is a marked departure...
Here’s Our Take On Cempra Inc (CEMP)’s Delay
Cempra Inc (NASDAQ:CEMP) just announced that it may not meet its PDUFA for solithromycin, and the company has taken a big hit on the news. The response...
Cempra Inc. (CEMP) Stock: Levin Capital Cuts 300,000 Shares
Levin Capital Strategies, managed by John A. Levin, has revealed through a 13G filing that it has reduced its stake in Cempra Inc. (NASDAQ:CEMP). The...
Why Investors Are Buzzing About Threshold Pharmaceuticals, Enbridge, Facebook and More
With the third quarter officially wrapping up at the end of Friday’s close, unexpected volatility in either direction could potentially appear at...
Cempra Inc (CEMP) Has A Busy Fourth Quarter Coming Up
Those familiar with the biotech space will no doubt already be aware of the development solithromycin – Cempra Inc (NASDAQ:CEMP)’s pneumonia drug....
Biotech Movers: Insys Therapeutics Inc (INSY) and Cempra Inc (CEMP)
The long weekend is over in the US, and the markets are back in full swing on Tuesday. We’ve already seen some strong moves in the biotech sector –...
What Has These Insiders Excited About Their Companies’ Stock?
Investors have been monitoring insider trading activity for years, as corporate insiders surely have more in-depth knowledge about their companies’...
What’s The Deal With These Sinking Stocks?
It’s Tuesday and shareholders of Depomed Inc (NASDAQ:DEPO), Allegheny Technologies Incorporated (NYSE:ATI), Cempra Inc (NASDAQ:CEMP), and Hexcel...
Why Are These Stocks Surging?
At a time when the S&P is roughly flat, shares of Weight Watchers International, Inc. (NYSE:WTW), Cempra Inc (NASDAQ:CEMP), Diebold Inc (NYSE:DBD...
Why Are These Stocks Trending In The Wrong Direction Today?
Both the NASDAQ and S&P 500 are slightly in the green this morning as positive momentum continues to buffet the market. However not all stocks are...
More Than 60% Returns For These Two Hedgies’ Favorite Health Care Picks
The health care sector has appreciated by nearly 30% over the past year. We decided to take a look at three companies that two health care-focused funds...
Aisling Capital Reduces Stake in Cempra Inc (CEMP)
Dennis Purcell‘s Aisling Capital recently filed an amended 13D with the SEC disclosing a reduced stake in Cempra Inc (NASDAQ:CEMP). According to...
Esperion Therapeutics Inc (ESPR), Cempra Inc (CEMP), Zeltiq Aesthetics Inc (ZLTQ): Aisling Capital’s Winning Plays in Small-Cap Healthcare Stocks
On Tuesday, Esperion Therapeutics Inc (NASDAQ:ESPR)‘s stock closed the trading section as one of the market leaders, ending the day up by 29%. The...
OncoGenex Pharmaceuticals Inc (OGXI): Are Hedge Funds Right About This Stock?
Is OncoGenex Pharmaceuticals Inc (NASDAQ:OGXI) a cheap investment today? Money managers are getting more bullish. The number of long hedge fund bets improved...
Is ShangPharma Corp (ADR) (SHP) Going to Burn These Hedge Funds?
ShangPharma Corp (ADR) (NYSE:SHP) has experienced an increase in hedge fund interest in recent months. If you’d ask most traders, hedge funds are...
